Biophysical Characterization of Therapeutic Antibodies


Sep 2017 - Aug 2019
Currently, there is an increased use of monoclonal antibodies in the context of the treatment of patients that suffer from cancer. In cooperation with a leading, internationally operating pharma company, this research group in Linz investigates the function of these innovative therapeutics on a molecular level.

Research program


J. Strasser, R. de Jong, F. Beurskens, G. Wang, A. Heck, J. Schuurman, P. Parren, P. Hinterdorfer, J. Preiner - Unraveling the Macromolecular Pathways of IgG Oligomerization and Complement Activation on Antigenic Surfaces - Nano Letters , 2019 more